spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Aganocide 

 HSMN NewsFeed - 20 Jan 2015
NovaBay Expands Sales Force for Avenova
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 11 Mar 2013
NovaBay Names Keith Bley as Senior Vice President of Product Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Sep 2012
NovaBay's NeutroPhase(R) Used in New Therapeutic Technique for Management of Necrotizing Fasciitis
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 14 Oct 2011
NovaBay Pharmaceuticals Spotlights NeutroPhase(R) at the Symposium on Advanced Wound Care (SAWC)
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 4 Oct 2011
NovaBay Pharmaceuticals Names David W. Stroman, Ph.D. as Head of Ophthalmic Drug Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Sep 2011
NovaBay Pharmaceuticals Names Russell A. Hoon as Vice President of Its Advanced Wound Care Business Unit
Biopharmaceuticals Wound Care Personnel
 HSMN NewsFeed - 16 Jun 2011
NovaBay Regains Worldwide Rights to Its Aganocide Compounds From Alcon
Biopharmaceuticals Licensing
 HSMN NewsFeed - 11 Oct 2010
NovaBay Pharmaceuticals Appoints Gail Maderis, BayBio President and CEO and Former Genzyme Senior Executive, to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Oct 2009
NovaBay Pharmaceuticals Expands Management Team; Names Mark Anderson, Ph.D. as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Aug 2009
NovaBay(R) Pharmaceuticals Names Roy J. Wu as Senior Vice President for Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Mar 2009
NovaBay and Galderma Enter Into Global Agreement to Develop and Commercialize NovaBay's Novel Aganocide Drugs for Major Dermatological Conditions
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 20 Jan 2009
NovaBay (NBY) Appoints Harry F. Hixson, Jr., PhD, Former Amgen President/Chief Operating Officer to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Jan 2008
NovaBay Pharmaceutical's Investigational New Drug Application (IND) for the Prevention of Catheter Associated Urinary Tract Infections Cleared by FDA
Biopharmacuticals
 HSMN NewsFeed - 21 Feb 2007
NovaCal Pharmaceuticals Has Changed Its Name to NovaBay Pharmaceuticals
Biopharmaceuticals
 HSMN NewsFeed - 18 Sep 2006
Alcon Licenses Novel Anti-Infective Compounds for Eye, Ear and Sinus Infections from NovaCal
Biopharmaceuticals Ophthalmology Licensing
 HSMN NewsFeed - 18 Sep 2006
NovaCal Licenses Novel Anti-Infective Compounds for Eye, Ear and Sinus Infections to Alcon
Biopharmaceuticals Ophthalmology Licensing
Return to NewsFeed  

 Additional items found! 1

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 1 additional stories matching:
Aganocide
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.